Výsledky vyhledávání - "I. Patrikeeva"

POS1082 CHARACTERISTICS OF PSORIATIC ARTHRITIS (PSA) PATIENTS WITH ENTHESITIS. DATA FROM RUSSIAN PSA REGISTRY (RU-PSART)

Autor: E. Loginova, T. Korotaeva, E. Gubar, Y. Korsakova, S. Glukhova, E. Nasonov, V. Sorotskaya, I. Patrikeeva, P. Shesternya, I. Shchendrigin

Publikováno v: Annals of the Rheumatic Diseases. 81:867-867

BackgroundPsoriatic arthritis (PsA) is a disease with multidomain clinical presentation such as arthritis, enthesitis, dactylitis, spondylitis and psoriasis (PsO). [1]. Enthesitis is a key clinical feature of PsA with significant impact on function,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d572071d40a8e6c2f304e5183680e44
https://doi.org/10.1136/annrheumdis-2022-eular.2554

Zobrazit plný text záznamu

POS1090 THE IMPACT OF NUMBER OF COMORBIDITIES ON ACHIEVEMENT REMISSION OR LOW DISEASE ACTIVITY BY DAPSA IN PSORIATIC ARTHRITIS. DATA FROM THE RUSSIAN OBSERVATIONAL COHORT

Autor: Y. Korsakova, E. Gubar, E. Loginova, T. Korotaeva, V. Sorotskaya, I. Patrikeeva, P. Shesternya, I. Umnova, E. Nasonov

Publikováno v: Annals of the Rheumatic Diseases. 81:871.2-872

BackgroundThe goal of psoriatic arthritis (PsA) treatment is achievement remission (REM) or Low Disease Activity (LDA) by DAPSA. The impact of comorbidities, especially obesity, metabolic syndrome on PsA activity and on biological treatment response

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::82a1c46437d63eec00bff4559869bfd9
https://doi.org/10.1136/annrheumdis-2022-eular.3308

Zobrazit plný text záznamu

AB0934 Does the severity of psoriasis impact on psoriatic arthritis activity? Data from rheumatological clinical practice

Autor: M. Chamurlieva, E. Loginova, T. Korotaeva, Y. Korsakova, E. Gubar, L. Vorobyova, P. Tremaskina, S. Glukhova, A. Lila, I. Patrikeeva, P. Shesternya

Publikováno v: Annals of the Rheumatic Diseases. 81:1595.2-1595

BackgroundPsoriatic arthritis (PsA) is a chronic, musculoskeletal inflammatory disease that develops in up to 30% of patients (pts) with psoriasis (PsO). There are conflicting data about correlations between skin and joint severity from the observati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fcf221d07bef91d8ed10c22757c0bd72
https://doi.org/10.1136/annrheumdis-2022-eular.2304

Zobrazit plný text záznamu

POS0976 ANALYSIS OF BIOLOGIC THERAPY RETENTION RATE IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUTV AXIAL INVOLVEMENT. DATA FROM CLINICAL PRACTICE

Autor: I. Patrikeeva, Irina Umnova, Svetlana Glukhova, Nasonov El, Elena Loginova, Y. Korsakova, Tatiana Korotaeva, V. Sorotskaya, E. Gubar, N. Kuznetsova

Publikováno v: Annals of the Rheumatic Diseases. 80:754-755

Background:Limited data are available on retention rates of biologic therapy in psoriatic arthritis (PsA) patients (pts) with axial involvement. It has been shown that in the subset of pts with prevalent axial involvement (AS versus PsA and AxSpA ver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e7068b7ce09b505095652c2828bfcf4
https://doi.org/10.1136/annrheumdis-2021-eular.2007

Zobrazit plný text záznamu

FRI0347 PREVALENCE OF OBESITY AND ITS LINK TO PSORIATIC ARTHRITIS (PSA) ACTIVITY AND RESPONSE TO THERAPY: DATA FROM THE RUSSIAN PSA REGISTRY (RU-PSART)

Autor: Elena Loginova, I. Patrikeeva, A. Vasilenko, E. Gubar, N. Kuznetsova, Y. Korsakova, E. Vasilenko, Nasonov El, Tatiana Korotaeva

Publikováno v: Annals of the Rheumatic Diseases. 79:768-769

Background:Obesity is a common comorbidity of psoriasis and PsA. It is connected to low-grade inflammation and it has a negative impact on the response to therapies. Although a high prevalence of obesity has been shown in a whole number of epidemiolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ffadd864a40e75482478e674da524da
https://doi.org/10.1136/annrheumdis-2020-eular.3314

Zobrazit plný text záznamu

AB0576 BONE EROSION IN PSORIATIC ARTHRITIS ASSOCIATED WITH PSORIASIS DURATION, SKIN, NAIL AND JOINT DISEASE SEVERITY

Autor: V. Sorotskaya, Nasonov El, N. Kuznetsova, Tatiana Korotaeva, Irina Umnova, M. Chamurlieva, Y. Korsakova, Elena Loginova, I. Shchendrigin, E. Gubar, I. Patrikeeva, Svetlana Glukhova

Publikováno v: Annals of the Rheumatic Diseases. 80:1325.2-1326

Background:Psoriatic arthritis (PsA) is heterogeneous in its clinical presentation and disease course, but many patients (pts) develop a destructive form of arthritis. Psoriasis (PsO) precedes arthritis by an average of 7 years. [1]. Theory of transi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9541e76d61637ce5b00a7a833b3255d8
https://doi.org/10.1136/annrheumdis-2021-eular.2796

Zobrazit plný text záznamu

POS1072 ASSOCIATION OF NAIL PSORIASIS WITH WORSE DISEASE OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS. DATA FROM CLINICAL PRACTICE

Autor: N. Kuznetsova, Elena Loginova, E. Gubar, I. Patrikeeva, Svetlana Glukhova, V. Sorotskaya, Irina Umnova, Y. Korsakova, Nasonov El, Alexander Lila, Tatiana Korotaeva

Publikováno v: Annals of the Rheumatic Diseases. 80:815.2-815

Background:Limited data are available regarding the burden of nail disease in psoriatic arthritis (PsA). The latest data show that nail involvement in PsA patients (pts) is associated with significantly more severe disease status (1).Objectives:To an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f07429054da6550e6284f38965c08135
https://doi.org/10.1136/annrheumdis-2021-eular.1576

Zobrazit plný text záznamu

AB0575 FACTORS ASSOCIATED WITH PSORIATIC ARTHRITIS ACTIVITY IN CLINICAL PRACTICE

Autor: N. Kuznetsova, Tatiana Korotaeva, I. Patrikeeva, Svetlana Glukhova, Elena Loginova, A. Vasilenko, E. Gubar, E. Vasilenko, Y. Korsakova, Nasonov El

Publikováno v: Annals of the Rheumatic Diseases. 80:1325.1-1325

Background:Psoriatic Arthritis (PsA) is a multifaceted disease with various clinical domains. A number of composite indices has been developed recently [1, 2]. DAPSA (Disease Activity in PSoriatic Arthritis) is the valid instrument for assessment of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3627ee118a23f482b2448550b25ed1d4
https://doi.org/10.1136/annrheumdis-2021-eular.2151

Zobrazit plný text záznamu

SAT0427 COMPARATIVE EFFECTIVENESS OF TOFACITINIB (TF) AND ADALIMUMAB (ADA) IN PSORIATIC ARTHRITIS (PsA) PATIENTS IN REAL CLINICAL PRACTICE

Autor: Tatiana Korotaeva, N. Kuznetsova, Elena Loginova, A. Vasilenko, E. Gubar, E. Vasilenko, I. Patrikeeva, Y. Korsakova, Svetlana Glukhova

Publikováno v: Annals of the Rheumatic Diseases. 79:1168.1-1168

Background:Tofacitinib (TF) is an oral Janus kinase inhibitor approved for PsA treatment. It has demonstrated comparable to ADA efficacy in RCT in reducing PsA clinical symptoms1,2. There is currently no data concerning comparative effectiveness of T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4c6e9d8fa40ec21e7c3f54a36afe0c3f
https://doi.org/10.1136/annrheumdis-2020-eular.1818

Zobrazit plný text záznamu

SAT0424 OBESITY LINKS TO PSORIATIC ARTHRITIS (PsA) ACTIVITY, HIGHER PREVALENCE OF CARDIOMETABOLIC DISORDERS AND WORSE PATIENT REPORTED OUTCOMES (PROs): DATA FROM THE RUSSIAN PsA REGISTRY (RU-PsART)

Autor: I. Patrikeeva, Y. Korsakova, N. Kuznetsova, Tatiana Korotaeva, E. Vasilenko, Elena Loginova, A. Vasilenko, E. Gubar, Nasonov El, Alexander Lila

Publikováno v: Annals of the Rheumatic Diseases. 79:1166.2-1166

Background:PsA patients (pts) have an increased risk of cardiovascular (CV) and metabolic (Met) disorders due to the combination of inflammation and increased prevalence of traditional CV risk factors. Only limited data are available on Russian PsA p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04c447d885394dc2a0cfe00e4ea28be5
https://doi.org/10.1136/annrheumdis-2020-eular.5538

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání